Experience cardiac care with nationally recognized outcomes at a local level. Dr. Longoria understands that being diagnosed with any cardiac condition can be overwhelming for patients and families. His goals are to alleviate you and your families concerns and guide you through the process. From structural heart interventions to complex cardio-thoracic procedures, Dr. Longoria offers world-class cardiac care to return to you to your optimal health.
Common Procedures Performed
Heart Valve Surgery
Patient Webinar: “Advantages of the Ross Procedure” with Dr. Stelzer & Dr. El-Hamamsy
by Adam Pick on November 12, 2020 at 6:03 pm
Top 5 New Posts From The Heart Valve Learning Center!
by Adam Pick on November 5, 2020 at 2:22 pm
Is This “Love Cat” with 3 Furry Hearts Trying to Tell Us Something?
by Adam Pick on October 22, 2020 at 2:43 pm
What to do when things go wrong
by McKenzie, D. on November 26, 2020 at 1:47 pm
Hippocrates’ famous decree, ‘First do no harm’, was an honourable but impossible aspiration. Hippocrates practised medicine at a time when human dissection was forbidden in Greece. Undoubtedly, the resulting lack of knowledge on disease processes would have led to unintentional patient harm. In medicine, all physicians will inevitably fail to uphold the eponymous oath which many swear to, and this has contributed to the difficult relationship we have with medical error. Healthcare is an inherently risky activity and cardiology is particularly dangerous due to the conditions that our patients present with and the procedures that we undertake to diagnose and treat them. It is a very uncomfortable situation when things go wrong, but accepting that occasionally they will and having the skills to manage them when they do are both vitally important. Imagine what you would want to happen if you were a patient or the relative of a...
Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure
by Marini, C., Fragasso, G., Italia, L., Sisakian, H., Tufaro, V., Ingallina, G., Stella, S., Ancona, F., Loiacono, F., Innelli, P., Costantino, M. F., Sahakyan, L., Gabrielyan, S., Avetisyan, M., Margonato, A., Agricola, E. on November 26, 2020 at 1:47 pm
ObjectivePulmonary congestion is the main cause of hospital admission in patients with heart failure (HF). Lung ultrasound (LUS) is a useful tool to identify subclinical pulmonary congestion. We evaluated the usefulness of LUS in addition to physical examination (PE) in the management of outpatients with HF. MethodsIn this randomised multicentre unblinded study, patients with chronic HF and optimised medical therapy were randomised in two groups: ‘PE+LUS’ group undergoing PE and LUS and ‘PE only’ group. Diuretic therapy was modified according to LUS findings and PE, respectively. The primary endpoint was the reduction in hospitalisation rate for acute decompensated heart failure (ADHF) at 90-day follow-up. Secondary endpoints were reduction in NT-proBNP, quality-of-life test (QLT) and cardiac mortality at 90-day follow-up. ResultsA total of 244 patients with chronic HF and optimised medical therapy were enrolled and randomised in ‘PE+LUS’ group undergoing PE and LUS, and in ‘PE only’ group. Thirty-seven primary outcome events occurred. The hospitalisation for ADHF at 90 day was significantly reduced in ‘PE+LUS’ group (9.4% vs 21.4% in ‘PE only’ group; relative risk=0.44; 95% CI 0.23 to 0.84; p=0.01), with a reduction of risk for hospitalisation for ADHF by 56% (p=0.01) and a number needed to treat of 8.4 patients (95% CI 4.8 to 34.3). At day 90, NT-proBNP and QLT score were significantly reduced in ‘PE+LUS’ group, whereas in ‘PE only’ group both were increased. There were no differences in mortality between the two groups. ConclusionsLUS-guided management reduces hospitalisation for ADHF at mid-term follow-up in outpatients with chronic HF.
Familial hypercholesterolaemia: history, diagnosis, screening, management and challenges
by Schmidt, E. B., Hedegaard, B. S., Retterstol, K. on November 26, 2020 at 1:47 pm
Learning objectives Acknowledge the history of familial hypercholesterolaemia (FH). Understand the pathophysiology of FH. Acknowledge the importance and significance of FH. Make a diagnosis of FH. Acknowledge the importance of (genetic) screening for FH. Acquire basic knowledge about treatment of FH. HistoryClinical familial hypercholesterolaemia (FH) was systematically described for the first time in 1937. In 17 families and in four generations, xanthomatosis, hypercholesterolaemia and cardiovascular disease (CVD) followed a pattern of an inborn error of metabolism and monogenetic autosomal dominant inheritance.1–3 However, single-patient cases of xanthomatosis and CVD had been reported as early as in 1873 by Fagge, by Lebzen and Knauss in 1889, by Török in 1893 and by Raeder in 1936.4 GeneticsIn 1964, the clinical heterozygous and homozygous forms of the disease were described3...
Study Casts Doubt on Plasma as COVID Treatment
on November 25, 2020 at 6:14 pm
Early in the COVID-19 pandemic, anecdotal reports suggested that infusing very sick patients with the blood plasma of people who'd survived the disease might help boost outcomes. But new study findings, along with disappointing results from prior trials, suggest that those initial hopes may have been unfounded.
Leaders Urge Caution as COVID Surges in Nursing Homes
on November 25, 2020 at 6:00 pm
Coronavirus cases in the nation’s 15,600 nursing homes have reached a record high, leaving operators struggling to protect staff and residents.
Experts: COVID Vaccine May Cause Side Effects
on November 25, 2020 at 2:38 pm
Americans who get a shot shouldn't be surprised if they feel under the weather for a few days afterwards, expert say. Vaccines work to fight disease by producing an immune response within the body. And sometimes that means flu-like symptoms, such as aches, headache and fever.